Ohio State University Comprehensive Cancer Center: Colorectal Neoplasms trials

The registry lists 14 Colorectal Neoplasms studies with Ohio State University Comprehensive Cancer Center as lead sponsor. 1 are open to participants now and 4 have results posted.

Phase 2 2No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Ohio State University (OSU) SCREEN Community ProgramRecruitingNCT06666192Not applicable
• Online Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF TrialCompletedNCT06016725Not applicableResults posted
• Audio and Video Brochures for Increasing Colorectal Cancer Screening Among Adults Living in AppalachiaCompletedNCT05810714Not applicableResults posted
• Rural Interventions for Screening EffectivenessCompletedNCT02795104Not applicableResults posted
• 2 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal CancerCompletedNCT01821105Phase 2Results posted
• A Dietary Intervention (Soy Soft Pretzels) for Reducing Chronic Inflammation in Obese IndividualsActive, not recruitingNCT07650409Not applicable
• Online Mindfulness-Based Intervention to Decrease Pre-Procedural Anxiety Before a First-Time Screening ColonoscopyCompletedNCT06233253Not applicable
• Blood Test (Guardant Shield™) for Screening of Colorectal Cancer in Underserved PatientsCompletedNCT05716477
• Dietary Patterns, Metabolomics and Colorectal Cancer RiskCompletedNCT03364582
• Educational Intervention - Improving Knowledge and Screening Rates for Colorectal CancerCompletedNCT03287453Not applicable
• CBPR Strategies to Increase Colorectal Cancer Screening in Ohio AppalachiaCompletedNCT01904656Not applicable
• Ohio Colorectal Cancer Prevention InitiativeCompletedNCT01850654Not applicable
• Testing Interventions to Motivate and EducateCompletedNCT01568151Not applicable
• Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal CancerCompletedNCT00005864Phase 2